MiR-497 suppresses angiogenesis in breast carcinoma by targeting HIF-1α

Oncology Reports

Volumn 35, Issue 3, 2016, Pages 1696-1702

  Wu, Zhihao ^a   Cai, Xuehong ^b   Huang, Chenggang ^b   Xu, Jia ^b   Liu, An ^b  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b First People's Hospital of Yueyang   (China)

Author keywords

Angiogenesis; Breast cancer; HIF 1 ; MiR 497; VEGF

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; MICRORNA; MICRORNA 497; UNCLASSIFIED DRUG; VASCULOTROPIN; HIF1A PROTEIN, HUMAN; MIRN497 MICRORNA, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CANCER INHIBITION; CANCER TISSUE; CARCINOGENICITY; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; DOWN REGULATION; ECTOPIC EXPRESSION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; MCF 7 CELL LINE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; STABLE TRANSFECTION; TUMOR VASCULARIZATION; TUMOR XENOGRAFT; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; BREAST TUMOR; CELL HYPOXIA; FEMALE; GENETICS; MCF-7 CELL LINE; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; BREAST NEOPLASMS; CELL HYPOXIA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MCF-7 CELLS; MICE; MICRORNAS; NEOVASCULARIZATION, PATHOLOGIC; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84955438854     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2015.4529     Document Type: Article

References (25)

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin 65: 87-108, 2015.
2. Schulze A and Harris AL: How cancer metabolism is tuned for proliferation and vulnerable to disruption. Nature 491: 364-373, 2012.
3. Parks SK, Chiche J and Pouyssegur J: Disrupting proton dynamics and energy metabolism for cancer therapy. Nat Rev Cancer 13: 611-623, 2013.
4. Zheng R, Yao Q, Xie G, Du S, Ren C, Wang Y and Yuan Y: TAT-ODD-p53 enhances the radiosensitivity of hypoxic breast cancer cells by inhibiting Parkin-mediated mitophagy. Oncotarget 6: 17417-17429, 2015.
5. Hamdan FH and Zihlif MA: Gene expression alterations in chronic hypoxic MCF7 breast cancer cell line. Genomics 104: 477-481, 2014.
6. Soares RJ, Cagnin S, Chemello F, Silvestrin M, Musaro A, De Pitta C, Lanfranchi G and Sandri M: Involvement of microRNAs in the regulation of muscle wasting during catabolic conditions. J Biol Chem 289: 21909-21925, 2014.
7. Godnic I, Zorc M, Jevsinek Skok D, Calin GA, Horvat S, Dovc P, Kovac M and Kunej T: Genome-wide and species-wide in silico screening for intragenic MicroRNAs in human, mouse and chicken. PLoS One 8: e65165, 2013.
8. Gromak N, Dienstbier M, Macias S, Plass M, Eyras E, Caceres JF and Proudfoot NJ: Drosha regulates gene expression independently of RNA cleavage function. Cell Rep 5: 1499-1510, 2013.
9. Zhai H, Chen QJ, Chen BD, Yang YN, Ma YT, Li XM, Liu F, Yu ZX, Xiang Y, Liao W, et al: Long noncoding RNA MALAT1 as a putative biomarker of lymph node metastasis: A meta.analysis. Int J Clin Exp Med 8: 7648-7654, 2015.
10. Nagpal N, Ahmad HM, Chameettachal S, Sundar D, Ghosh S and Kulshreshtha R: HIF-inducible miR-191 promotes migration in breast cancer through complex regulation of TGFsignaling in hypoxic microenvironment. Sci Rep 5: 9650, 2015.
11. Chen W, Cai F, Zhang B, Barekati Z and Zhong XY: The level of circulating miRNA-10b and miRNA-373 in detecting lymph node metastasis of breast cancer: Potential biomarkers. Tumour Biol 34: 455-462, 2013.
12. Du M, Shi D, Yuan L, Li P, Chu H, Qin C, Yin C, Zhang Z and Wang M: Circulating miR-497 and miR-663b in plasma are potential novel biomarkers for bladder cancer. Sci Rep 5: 10437, 2015.
13. Wei C, Luo Q, Sun X, Li D, Song H, Li X, Song J, Hua K and Fang L: microRNA-497 induces cell apoptosis by negatively regulating Bcl-2 protein expression at the posttranscriptional level in human breast cancer. Int J Clin Exp Pathol 8: 7729-7739, 2015.
14. Troppan K, Wenzl K, Pichler M, Pursche B, Schwarzenbacher D, Feichtinger J, Thallinger GG, Beham-Schmid C, Neumeister P and Deutsch A: miR-199a and miR-497 are associated with better overall survival due to increased chemosensitivity in diffuse large B-cell lymphoma patients. Int J Mol Sci 16: 18077.18095, 2015.
15. Han Z, Zhang Y, Yang Q, Liu B, Wu J, Zhang Y, Yang C and Jiang Y: miR-497 and miR-34a retard lung cancer growth by co-inhibiting cyclin E1 (CCNE1). Oncotarget 6: 13149-13163, 2015.
16. Peng L, Liu A, Shen Y, Xu HZ, Yang SZ, Ying XZ, Liao W, Liu HX, Lin ZQ, Chen QY, et al: Antitumor and anti-angiogenesis effects of thymoquinone on osteosarcoma through the NF-B pathway. Oncol Rep 29: 571-578, 2013.
17. Howell A, Anderson AS, Clarke RB, Duffy SW, Evans DG, Garcia-Closas M, Gescher AJ, Key TJ, Saxton JM and Harvie MN: Risk determination and prevention of breast cancer. Breast Cancer Res 16: 446, 2014.
18. Rinck A, Preusse M, Laggerbauer B, Lickert H, Engelhardt S and Theis FJ: The human transcriptome is enriched for miRNA.binding sites located in cooperativity-permitting distance. RNA Biol 10: 1125-1135, 2013.
19. Raychaudhuri S: MicroRNAs overexpressed in growth-restricted rat skeletal muscles regulate the glucose transport in cell culture targeting central TGF factor SMAD4. PLoS One 7: e34596, 2012.
20. Luo Q, Li X, Gao Y, Long Y, Chen L, Huang Y and Fang L: MiRNA-497 regulates cell growth and invasion by targeting cyclin E1 in breast cancer. Cancer Cell Int 13: 95, 2013.
21. Liu Y, Wondimu A, Yan S, Bobb D and Ladisch S: Tumor gangliosides accelerate murine tumor angiogenesis. Angiogenesis 17: 563-571, 2014.
22. Retsky M, Bonadonna G, Demicheli R, Folkman J, Hrushesky W and Valagussa P: Hypothesis: Induced angiogenesis after surgery in premenopausal node-positive breast cancer patients is a major underlying reason why adjuvant chemotherapy works particularly well for those patients. Breast Cancer Res 6: R372-R374, 2004.
23. Ma J, Zhang L, Ru GQ, Zhao ZS and Xu WJ: Upregulation of hypoxia inducible factor 1 mRNA is associated with elevated vascular endothelial growth factor expression and excessive angiogenesis and predicts a poor prognosis in gastric carcinoma. World J Gastroenterol 13: 1680-1686, 2007.
24. Dang K and Myers KA: The role of hypoxia-induced miR-210 in cancer progression. Int J Mol Sci 16: 6353-6372, 2015.
25. Meng F, Dong B, Li H, Fan D and Ding J: RNAi-mediated inhibition of Raf-1 leads to decreased angiogenesis and tumor growth in gastric cancer. Cancer Biol Ther 8: 174-179, 2009.